Loading…
Academic Journal
The problem of over-volunteering in early phase clinical trials
S. B. Fitilev, A. V. Vozzhaev, I. I. Shkrebniova, D. A. Kliuev
Качественная клиническая практика, Vol 0, Iss 2, Pp 58-63 (2018)
Saved in:
| Title | The problem of over-volunteering in early phase clinical trials |
|---|---|
| Authors | S. B. Fitilev, A. V. Vozzhaev, I. I. Shkrebniova, D. A. Kliuev |
| Publication Year |
2018
|
| Source |
Качественная клиническая практика, Vol 0, Iss 2, Pp 58-63 (2018)
|
| Description |
This article discusses important problem of early phase clinical trials – over-volunteering. The overlapping or dual enrollment of healthy volunteers is a potential high risk not only to study subjects, but also to commercial sponsors because it could cause the delay in advancement of promising drug candidates. The problem of over-volunteering is payed special attention by clinical research professionals in foreign countries. Guidelines for early phase clinical trials recommend implementation of different control and prevention measures of multiple enrollment. The most effective instrument to prevent over-volunteering is considered to be a central internet-based registry of healthy volunteers. Such registries operate in various countries and differ in structure, scope of information collected, types of funding and management. The general operating principles of such registries are described on the example of TOPS data base. TOPS is а special system to prevent over-volunteering that is used by UK phase 1 units. In conclusion, authors urge regulatory authorities and pharmaceutical companies to approach this problem closely because over-volunteering is already a burning issue in our country. It is essential to improve relevant regulatory framework and launch central registries of healthy subjects with regard to international experience.
|
| Document Type |
article
|
| Language |
Russian
|
| Publisher Information |
Izdatelstvo OKI, 2018.
|
| Subject Terms | |
